Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Mechanisms by which IGF-I may promote cancer Grimberg ACancer Biol Ther 2003[Nov]; 2 (6): 630-5Multiple large case-control studies in the past five years have reported positive associations between high circulating levels of the insulin-like growth factor (IGF)-I and risk for different types of cancer. Correlations certainly do not prove causation, but the reproducibility of this finding implies this is a hypothesis worth further examination through more mechanistic studies. IGF-I binds to the IGF-I receptor, a tyrosine kinase receptor that transduces signals to the nucleus and mitochondrion primarily via the mitogen-activated protein kinase (MAPK) and PI3K/Akt pathways. Examples will be provided to illustrate how IGF-I signaling may contribute to each stage of cancer progression: malignant transformation, tumor growth, local invasion and distant metastases, and resistance to treatment. In addition to direct contributions to each of these stages, IGF-I may promote cancer indirectly, through interactions with oncogenes and tumor suppressors, interactions with other hormones (especially the sex steroids in breast and prostate cancers) and interactions with the IGF binding proteins (IGFBPs). Finally, circulating IGF-I may facilitate cancer development though it likely does not cause cancer to form. Prompted by the accumulating evidence, investigations are also being pursued to modulate the IGF system as a possible means of cancer prevention or treatment.|Animals[MESH]|Cell Transformation, Neoplastic/metabolism[MESH]|Humans[MESH]|Insulin-Like Growth Factor Binding Proteins/blood/physiology[MESH]|Insulin-Like Growth Factor I/*physiology[MESH]|Mitogen-Activated Protein Kinases/metabolism[MESH]|Models, Biological[MESH]|Neoplasm Metastasis[MESH]|Neoplasms/blood/*etiology[MESH]|Phosphatidylinositol 3-Kinases/metabolism[MESH]|Phosphorylation[MESH]|Protein Serine-Threonine Kinases/metabolism[MESH]|Protein Structure, Tertiary[MESH]|Proto-Oncogene Proteins c-akt[MESH]|Proto-Oncogene Proteins/metabolism[MESH]|Receptor, IGF Type 1/chemistry/physiology[MESH]|Risk Factors[MESH]|Signal Transduction[MESH]|Structure-Activity Relationship[MESH] |
